Business Description
Sionna Therapeutics Inc. is a Waltham, Massachusetts-based company founded in 2019 and focused solely on finding better treatments for cystic fibrosis. The company has built a broad pipeline of experimental drugs, several of which have already advanced through early and mid-stage clinical trials. Each drug candidate targets a different part of the protein responsible for cystic fibrosis, with the goal of offering patients more effective options than those currently available.